PTC Therapeutics reports Q3 2026 results, raises revenue guidance, advances pipelineOct 29Quarterly updatePTC Therapeuticssepiapterin
PTC Therapeutics registers Phase 2A trial of PTC844 in rheumatoid arthritisAug 21Trial updatePTC TherapeuticsPTC844